Payment & Reimbursement

This case study explores implementation of medications for opioid use disorder (MOUD) through a partnership between a Missouri-based federally qualified health center (FQHC) and Certified Community Behavioral Health Clinic (CCBHC).

This report provides an update on the present state of coverage, availability of, and access to, medications for treating ongoing alcohol use disorder and opioid use disorder, and reversing an opioid overdose within state Medicaid plans.

The aim of the Lexicon is to describe the functions which define integrated behavioral health in primary care practices to clarify what to implement and what to expect.

This Topic Brief covers foundational information on disparities in health and healthcare (including in substance use disorder), the role of behavioral health integration in reducing disparities, and ensuring advancement of health equity within integrated care settings.

This issue brief provides federal and state policymakers with ways they can support low-threshold buprenorphine prescribing through reimbursement policies, treatment guidelines, and regulations.

This report, produced in collaboration with the Partnership to End Addiction, analyzes standards of prior authorization requirements in both public and private insurance plans.

This toolkit provides clinically relevant information to support high-quality delivery of outpatient OUD care via telehealth, while reducing barriers to starting and maintaining both medication and psychosocial treatments.

This web page includes toolkits, guides, and webinars (including on-demand training courses) available from the MOC.

This resource document provides practical, evidence-based information for primary care providers and practices on prescribing buprenorphine to individuals in need of intervention, including implementation considerations and strategies for primary care providers and primary care organizations.

This advisory introduces readers to digital therapeutics (DTx) and the benefits of their use in behavioral health. It describes the research, regulatory, and reimbursement implications for DTx as well as selection and implementation considerations.